Loading clinical trials...
Loading clinical trials...
A Phase I Dose Escalation Study of Oral MK-2206 in Patients With Locally Advanced or Metastatic Solid Tumors
Conditions
Interventions
MK-2206
Start Date
April 15, 2008
Primary Completion Date
July 11, 2011
Completion Date
July 11, 2011
Last Updated
April 1, 2019
NCT05245812
NCT05884320
NCT04550494
NCT04929028
NCT04235764
NCT06498635
Lead Sponsor
Merck Sharp & Dohme LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions